| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/28/2002 | WO2001053339A3 Egg specific surface proteins |
| 02/28/2002 | WO2001051639A3 Everninomicin biosynthetic genes |
| 02/28/2002 | WO2001042474A3 Interferon-like molecules and uses thereof |
| 02/28/2002 | WO2001042462A3 Phospholipase a2 inhibitory peptides from python reticulatus |
| 02/28/2002 | WO2001040266A3 Insect poison allergens with reduced ige reactivity and method for producing the same |
| 02/28/2002 | WO2001038547A3 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 02/28/2002 | WO2001038500A3 Tetrahydropyrimidine oxygenase gene, polypeptides encoded by said gene and method for producing the same |
| 02/28/2002 | WO2001036614A3 The genome of the hiv-1 inter-subtype (c/b') and use thereof |
| 02/28/2002 | WO2001032851A3 Modular transport systems for molecular substances and production and use thereof |
| 02/28/2002 | WO2001032702A3 Molecular structure of rhd negative locus |
| 02/28/2002 | WO2001031029A3 Human sphingosine kinase gene |
| 02/28/2002 | WO2001030812A3 Activation of hcv-specific t cells |
| 02/28/2002 | WO2001027284A3 Recombinant megalomicin biosynthetic genes and uses thereof |
| 02/28/2002 | WO2001027261A3 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 02/28/2002 | WO2001027254A3 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 02/28/2002 | WO2001025469A3 Method for preparing steroids modified by yeast fermentation |
| 02/28/2002 | WO2001023414B1 Immunologically significant herpes simplex virus antigens |
| 02/28/2002 | WO2001015755A3 Methods and compositions for delivery of pharmaceutical agents |
| 02/28/2002 | WO2001005422A3 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 02/28/2002 | WO2000077037A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/28/2002 | WO2000056875A9 Detection, cloning and sequencing of polypeptides which drive the subcellular localization of proteins |
| 02/28/2002 | WO2000050566A3 Genes encoding insect odorant receptors and uses thereof |
| 02/28/2002 | US20020026658 Adjustment of plant metabolism |
| 02/28/2002 | US20020026657 Genetic control of fruit ripening |
| 02/28/2002 | US20020026653 Expression vector for use in classification of gene activity and prevention and treatment defects associated with enzymatic disorders |
| 02/28/2002 | US20020026652 Transgenic mice containing cGMP phosphodiesterase gene disruptions |
| 02/28/2002 | US20020026651 Pathogenic tau mutations |
| 02/28/2002 | US20020026650 Migrating nucleotide sequences; for as diagnostic tools in the detection of migrating genomic sequences |
| 02/28/2002 | US20020026649 Metastasis models using green fluorescent protein (GFP) as a marker |
| 02/28/2002 | US20020026288 Chip, genomic drug prescription support system, chip information offering system, chip supply system,and computer storage medium |
| 02/28/2002 | US20020026045 Rad23 genes and uses thereof |
| 02/28/2002 | US20020026044 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing |
| 02/28/2002 | US20020026040 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases |
| 02/28/2002 | US20020026037 For diagnosing and treating disorders related to this novel human protein such as disorders related to the vascular and lymphatic systems |
| 02/28/2002 | US20020026036 Constructing cassette vector by inserting cDNA coding for heavy chain constant region of human antibody into expression vector for animal cell use, establishing cloning site, digesting cdna coding for heavy chain, inserting into vector |
| 02/28/2002 | US20020026033 Synthetic glycosulfopeptides and methods of synthesis thereof |
| 02/28/2002 | US20020025939 Chorionic gonadortropin dna vaccines and methods |
| 02/28/2002 | US20020025931 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor |
| 02/28/2002 | US20020025929 Concurrent aministering parathyroid hormone and benzothiophene compound |
| 02/28/2002 | US20020025923 Antiinflammatory agents |
| 02/28/2002 | US20020025578 Intensified expression of nucleotide sequences in mammal; administer nucleic acids to mammal, transfect nucleotide sequence using voltage, monitor mammal for gene expression |
| 02/28/2002 | US20020025577 Eukaryotic gene expression cassette and uses thereof |
| 02/28/2002 | US20020025572 Separating nucleotide sequences in sample; obtain sample, extract nucleotide sequences, incubate sample with nucleotide sequence carrier, separate bound nucleotide sequences, dissociate nucleotide sequences, recover nucleotide sequences |
| 02/28/2002 | US20020025566 From dipeptides |
| 02/28/2002 | US20020025561 Assembling expression vectors; prepare overlapping nucleotide sequences, clone nucleic acids into vector, monitor accuracy of insert, digest clones, purify, anneal and tie nucleotide sequences, classify expression vector |
| 02/28/2002 | US20020025559 Nucleotide sequences for use in the diagnosis and treatment of hypertension, heart, and kidney defects |
| 02/28/2002 | US20020025558 Human MAD proteins and uses thereof |
| 02/28/2002 | US20020025557 32447, a novel human acyltransferase and uses thereof |
| 02/28/2002 | US20020025552 Detecting preferential nucleotide sequences in sample; obtain sample, screen, separate nucleotide sequences of interest, recover nucleotide sequences |
| 02/28/2002 | US20020025551 Novel molecules of the t129-related protein family and uses thereof |
| 02/28/2002 | US20020025550 Methods for producing highly phosphorylated lysosomal hydrolases |
| 02/28/2002 | US20020025543 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 02/28/2002 | US20020025540 Isolation of functionally active gamma- secretase protein complex and methods for detection of activity and Inhibitors thereof |
| 02/28/2002 | US20020025533 Monitoring sample for the presence of preferential particles; provide apparatus, insert sample, generate alternating fluid flow, monitor and detect signal |
| 02/28/2002 | US20020025531 Method of determining analytical nucleotide sequence used in nucleic acid detection |
| 02/28/2002 | US20020025530 PCR-based multiplex assay for determining haplotype |
| 02/28/2002 | US20020025525 Methods for detecting contamination in molecular diagnostics using PCR |
| 02/28/2002 | US20020025519 Methods and oligonucleotides for detecting nucleic acid sequence variations |
| 02/28/2002 | US20020025517 Methods and compositions for cellular and metabolic engineering |
| 02/28/2002 | US20020025516 Nrde |
| 02/28/2002 | US20020025328 As vaccines for immunization |
| 02/28/2002 | US20020025318 Transferrin-binding proteins from n.gonorrhoeae and n. meningitidis |
| 02/28/2002 | US20020025317 For therapy and prophylaxis of pathological condition associated with expression of Interelukin-12 and/or Interleukin-18, including excessive or inappropriate amounts of those cytokines |
| 02/28/2002 | US20020025307 Gene therapy, testing |
| 02/28/2002 | US20020025305 Cell-cycle regulatory proteins, and uses related thereto |
| 02/28/2002 | US20020025297 Methods of screening agents for activity using teleosts |
| 02/28/2002 | DE10040379A1 Pflanzen mit veränderten Wachstumseigenschaften Plants with altered growth characteristics |
| 02/28/2002 | DE10040289A1 Verfahren zur Herstellung und Ermittlung geeigneter Effektoren von Zielmolekülen mit Substanzbibliotheken Methods for preparing and identifying appropriate effectors of target molecules with libraries |
| 02/28/2002 | DE10040179A1 Beeinflussung der Verteilung von Metallen in transgenen Pflanzen Influencing the distribution of metals in transgenic plants |
| 02/28/2002 | DE10039584A1 New polymorphic form of c-Fos, useful e.g. in animal breeding, diagnosis of diseases comprises a transversion at position 2910 |
| 02/28/2002 | DE10036469A1 Ultraspiracle (USP)-Protein von Heliothis virescens Ultraspiracle (USP) protein of Heliothis virescens |
| 02/28/2002 | DE10034729A1 Regulatorische Sequenzen aus meristematischen Zellen Regulatory sequences from meristematic cells |
| 02/28/2002 | CA2708605A1 Nucleotide sequences of a new class of diverged delta-9 stearoyl-acp desaturase genes |
| 02/28/2002 | CA2674888A1 Anti-ige vaccines |
| 02/28/2002 | CA2674838A1 Anti-ige vaccines |
| 02/28/2002 | CA2456008A1 Stem cell differentiation |
| 02/28/2002 | CA2421062A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/28/2002 | CA2421059A1 Constructs and their use in metabolic pathway engineering |
| 02/28/2002 | CA2421057A1 Methods and reagents for molecular cloning |
| 02/28/2002 | CA2420721A1 Method for massive directed mutagenesis |
| 02/28/2002 | CA2420543A1 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/28/2002 | CA2420538A1 Novel proteins and nucleic acids encoding same |
| 02/28/2002 | CA2420534A1 An iap binding peptide or polypeptide and methods of using the same |
| 02/28/2002 | CA2420499A1 Methods of treatment or prevention of autoimmune diseases with cpg-containing polynucleotide |
| 02/28/2002 | CA2420490A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/28/2002 | CA2420487A1 Novel human proteases and polynucleotides encoding the same |
| 02/28/2002 | CA2420482A1 Progression suppressed gene 13 (psgen 13) and uses thereof |
| 02/28/2002 | CA2420477A1 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 02/28/2002 | CA2420393A1 Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals |
| 02/28/2002 | CA2420328A1 Synthetic nucleic acid molecule compositions and methods of preparation |
| 02/28/2002 | CA2420325A1 Plant polynucleotides encoding novel prenyl proteases |
| 02/28/2002 | CA2420316A1 Self-excising polynucleotides and uses thereof |
| 02/28/2002 | CA2420261A1 Genes and proteins, and their uses |
| 02/28/2002 | CA2420260A1 Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells |
| 02/28/2002 | CA2420257A1 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | CA2420251A1 Dna binding peptide domains and a method for providing such domains |
| 02/28/2002 | CA2420233A1 Method for identifying substances useful for treating inflammation using the response element to the i.kappa.b.alpha. ror receptor |
| 02/28/2002 | CA2420198A1 Calycins |
| 02/28/2002 | CA2420193A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | CA2420176A1 Compositions and methods for the diagnosis and treatment of tumor |